Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2019

18.05.2019 | Research Article

Perceptions of medicine use among pregnant women: an interview-based study

verfasst von: Rasmus Søgaard Nyholm, Jon Trærup Andersen, Charlotte Vermehren, Susanne Kaae

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background When women are in a condition that requires medicines during pregnancy they have to balance the health benefits of the medical treatment against the potential risk of harming their unborn child. Too high teratogenic risk perceptions among pregnant women can lead them to stop taking the medicine, worsening the symptoms for the mother and even harming their foetus. Many women today who use over-the-counter and prescribed medicines have been shown to change their medical behaviour when they become pregnant. Objective To explore in depth the perceptions of medication use among women during their pregnancy. Setting The Capital Region of Denmark. Methods Participants were recruited from social network groups on Facebook and from participants in lectures and antenatal classes for pregnant women in two hospitals. Two focus groups interviews and three individual semi-structured interviews were conducted. The interview guides were based on existing literature and relatively unstructured, with an emphasis on open-ended questions. Interview transcripts were analysed using the phenomenological approach of meaning condensation. Main Outcome measure Pregnant women’s’ perceptions of medicine including aspects related to their safety feeling of medicines and perceived support from health care professionals. Results The women believed that it is less safe to take medicines during pregnancy, largely due to the risk of the child getting a disease in the future, but also due to the risk of malformation. Lack of clinical tests and uncertainty about how the unborn child reacts to medications were reported causes of these concerns. Most participants were concerned about using medicines and avoided them if possible, including over-the counter medicines. Conversations with physicians had a calming effect although the physicians appeared to be unclear in their guidance regarding dietary supplements. Some women received conflicting information on the Internet. Several suggestions were made about how to reduce uncertainties about the safety of taking medicines during pregnancy. Conclusion Many pregnant women are concerned about how to use medicines. To reduce these concerns and ensure the appropriate use of medicines during pregnancy, initiatives are needed to strengthen evidence-based advice from health care professionals, especially during the first trimester.
Literatur
1.
Zurück zum Zitat Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: a Saudi study. Saudi Pharm J. 2014;22(5):419–28.CrossRefPubMed Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: a Saudi study. Saudi Pharm J. 2014;22(5):419–28.CrossRefPubMed
2.
Zurück zum Zitat Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Nordeng H, Koren G, Einarson A. Pregnant women’s beliefs about medications—a study among 866 Norwegian women. Ann Pharmacother. 2010;44(9):1478–84.CrossRefPubMed Nordeng H, Koren G, Einarson A. Pregnant women’s beliefs about medications—a study among 866 Norwegian women. Ann Pharmacother. 2010;44(9):1478–84.CrossRefPubMed
4.
Zurück zum Zitat Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adher. 2018;12:1–8. Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adher. 2018;12:1–8.
5.
Zurück zum Zitat Csajka C, Jaquet A, Winterfeld U, Meyer Y, Einarson A, Panchaud A. Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey. Swiss Med Wkly. 2014;144:w13936.PubMed Csajka C, Jaquet A, Winterfeld U, Meyer Y, Einarson A, Panchaud A. Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey. Swiss Med Wkly. 2014;144:w13936.PubMed
6.
Zurück zum Zitat Widnes SF, Schjott J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Saf. 2013;36(6):481–9.CrossRefPubMed Widnes SF, Schjott J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Saf. 2013;36(6):481–9.CrossRefPubMed
7.
Zurück zum Zitat Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–176.CrossRefPubMedPubMedCentral Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–176.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Petersen I, McCrea RL, Osborn DJ, Evans S, Pinfold V, Cowen PJ, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014;159(1):218–25.CrossRefPubMed Petersen I, McCrea RL, Osborn DJ, Evans S, Pinfold V, Cowen PJ, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014;159(1):218–25.CrossRefPubMed
9.
Zurück zum Zitat Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979–85.CrossRefPubMed Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979–85.CrossRefPubMed
10.
Zurück zum Zitat Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm. 2014;36(1):145–53.CrossRefPubMed Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm. 2014;36(1):145–53.CrossRefPubMed
11.
Zurück zum Zitat Koren G. The way women perceive teratogenic risk. Can J Clin Pharmacol. 2007;14(1):e10–6.PubMed Koren G. The way women perceive teratogenic risk. Can J Clin Pharmacol. 2007;14(1):e10–6.PubMed
12.
Zurück zum Zitat Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–66.CrossRefPubMed Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–66.CrossRefPubMed
15.
Zurück zum Zitat Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.CrossRefPubMed Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.CrossRefPubMed
16.
Zurück zum Zitat Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey. BMJ Open. 2015;5(6):e007390.CrossRefPubMedPubMedCentral Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey. BMJ Open. 2015;5(6):e007390.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Widnes SF, Schjott J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216(4):375–8.CrossRefPubMed Widnes SF, Schjott J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216(4):375–8.CrossRefPubMed
18.
Zurück zum Zitat Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):127–31.CrossRefPubMed Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):127–31.CrossRefPubMed
19.
Zurück zum Zitat Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed
20.
Zurück zum Zitat Kaae S, Traulsen J. Qualitative methods in pharmacy practice research. In: Babar ZUD, editor. Pharmacy practice research methods. Adis/Springer: Cham; 2015. p. 49–68. Kaae S, Traulsen J. Qualitative methods in pharmacy practice research. In: Babar ZUD, editor. Pharmacy practice research methods. Adis/Springer: Cham; 2015. p. 49–68.
21.
22.
Zurück zum Zitat Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef
23.
Zurück zum Zitat Kvale S. Methods of analysis. In: Kvale S, editor. Interviews. An introduction to qualitative research interviewing. Thousand Oaks: SAGE Publications; 1996. p. 187–209. Kvale S. Methods of analysis. In: Kvale S, editor. Interviews. An introduction to qualitative research interviewing. Thousand Oaks: SAGE Publications; 1996. p. 187–209.
24.
Zurück zum Zitat Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res Part C Embryo Today Rev. 2015;105(2):140–56.CrossRef Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res Part C Embryo Today Rev. 2015;105(2):140–56.CrossRef
26.
Zurück zum Zitat McDonald K, Amir LH, Davey MA. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11(Suppl 5):S5.CrossRefPubMedPubMedCentral McDonald K, Amir LH, Davey MA. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11(Suppl 5):S5.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hippman C, Balneaves LG. Women’s decision making about antidepressant use during pregnancy: a narrative review. Depress Anxiety. 2018;35(12):1158–67.CrossRefPubMed Hippman C, Balneaves LG. Women’s decision making about antidepressant use during pregnancy: a narrative review. Depress Anxiety. 2018;35(12):1158–67.CrossRefPubMed
28.
Zurück zum Zitat Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66(7):657–64.CrossRefPubMed Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66(7):657–64.CrossRefPubMed
29.
Zurück zum Zitat Koren G, Pastuszak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 1990;41(6):657–61.CrossRefPubMed Koren G, Pastuszak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 1990;41(6):657–61.CrossRefPubMed
30.
Zurück zum Zitat Devkota R, Khan GM, Alam K, Sapkota B, Devkota D. Impacts of counseling on knowledge, attitude and practice of medication use during pregnancy. BMC Pregnancy Childbirth. 2017;17(1):131.CrossRefPubMedPubMedCentral Devkota R, Khan GM, Alam K, Sapkota B, Devkota D. Impacts of counseling on knowledge, attitude and practice of medication use during pregnancy. BMC Pregnancy Childbirth. 2017;17(1):131.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. Prim Care Companion CNS Disord. 2011;13(2), https://doi.org/10.4088/PCC.10m01028. Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. Prim Care Companion CNS Disord. 2011;13(2), https://​doi.​org/​10.​4088/​PCC.​10m01028.
32.
Zurück zum Zitat Gils C, Pottegard A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16:226.CrossRefPubMedPubMedCentral Gils C, Pottegard A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16:226.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Baron R, Heesterbeek Q, Mannien J, Hutton EK, Brug J, Westerman MJ. Exploring health education with midwives, as perceived by pregnant women in primary care: a qualitative study in the Netherlands. Midwifery. 2017;46:37–44.CrossRefPubMed Baron R, Heesterbeek Q, Mannien J, Hutton EK, Brug J, Westerman MJ. Exploring health education with midwives, as perceived by pregnant women in primary care: a qualitative study in the Netherlands. Midwifery. 2017;46:37–44.CrossRefPubMed
34.
Zurück zum Zitat McLaughlin K, Kable A, Ebert L, Murphy V. Midwives’ perception of their role in providing antenatal asthma management in Australia—a qualitative study. Midwifery. 2016;35:11–6.CrossRefPubMed McLaughlin K, Kable A, Ebert L, Murphy V. Midwives’ perception of their role in providing antenatal asthma management in Australia—a qualitative study. Midwifery. 2016;35:11–6.CrossRefPubMed
35.
Zurück zum Zitat Warriner S, Bryan K, Brown AM. Women’s attitude towards the use of complementary and alternative medicines (CAM) in pregnancy. Midwifery. 2014;30(1):138–43.CrossRefPubMed Warriner S, Bryan K, Brown AM. Women’s attitude towards the use of complementary and alternative medicines (CAM) in pregnancy. Midwifery. 2014;30(1):138–43.CrossRefPubMed
36.
Zurück zum Zitat Sinclair M, Lagan BM, Dolk H, McCullough JEM. An assessment of pregnant women’s knowledge and use of the Internet for medication safety information and purchase. J Adv Nurs. 2018;74(1):137–47.CrossRefPubMed Sinclair M, Lagan BM, Dolk H, McCullough JEM. An assessment of pregnant women’s knowledge and use of the Internet for medication safety information and purchase. J Adv Nurs. 2018;74(1):137–47.CrossRefPubMed
37.
Zurück zum Zitat De Santis M, De Luca C, Quattrocchi T, Visconti D, Cesari E, Mappa I, et al. Use of the Internet by women seeking information about potentially teratogenic agents. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):154–7.CrossRefPubMed De Santis M, De Luca C, Quattrocchi T, Visconti D, Cesari E, Mappa I, et al. Use of the Internet by women seeking information about potentially teratogenic agents. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):154–7.CrossRefPubMed
38.
Zurück zum Zitat Peters SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiol Drug Saf. 2013;22(3):324–8.CrossRefPubMed Peters SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiol Drug Saf. 2013;22(3):324–8.CrossRefPubMed
39.
Zurück zum Zitat Koren G, Bozzo P. Cost effectiveness of teratology counseling—the Motherisk experience. J Popul Ther Clin Pharmacol. 2014;21(2):e266–70.PubMed Koren G, Bozzo P. Cost effectiveness of teratology counseling—the Motherisk experience. J Popul Ther Clin Pharmacol. 2014;21(2):e266–70.PubMed
Metadaten
Titel
Perceptions of medicine use among pregnant women: an interview-based study
verfasst von
Rasmus Søgaard Nyholm
Jon Trærup Andersen
Charlotte Vermehren
Susanne Kaae
Publikationsdatum
18.05.2019
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2019
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00840-4

Weitere Artikel der Ausgabe 4/2019

International Journal of Clinical Pharmacy 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.